Assessment of bacterial contamination of three multidose ophthalmic solutions

Veterinary Ophthalmology

Volumn 10, Issue 2, 2007, Pages 81-83

  Betbeze, Caroline M ^a   Stiles, Jean ^a   Krohne, Sheryl G ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Aerobic culture; Bacterial contamination; Eye wash; Multidose ophthalmic solutions; Proparacaine; Tropicamide

Indexed keywords

EYE DROPS; LOCAL ANESTHETIC AGENT; MYDRIATIC AGENT; PROPOXYCAINE; PROXYMETACAINE; TROPICAMIDE; VETERINARY DRUG; WATER;

ANIMAL; ANIMAL DISEASE; ARTICLE; DRUG CONTAMINATION; DRUG STABILITY; DRUG STORAGE; EQUIPMENT; EVALUATION; ISOLATION AND PURIFICATION; STAPHYLOCOCCUS EPIDERMIDIS; VISUAL SYSTEM EXAMINATION;

ANESTHETICS, LOCAL; ANIMALS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRUG CONTAMINATION; DRUG STABILITY; DRUG STORAGE; EQUIPMENT CONTAMINATION; MYDRIATICS; OPHTHALMIC SOLUTIONS; PROPOXYCAINE; STAPHYLOCOCCUS EPIDERMIDIS; TROPICAMIDE; VETERINARY DRUGS; WATER;

ANIMALIA; BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS EPIDERMIDIS;

EID: 33847103169     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2007.00513.x     Document Type: Article

References (25)

1. Duffner LR, Pflugfelder SC, Mandelbaum S et al. Potential bacterial contamination in fluorescein-anesthetic solutions. American Journal of Ophthalmology 1990; 110: 199-202.
2. Tasli H, Cosar G. Microbial contamination of eye drops. Central European Journal of Public Health 2001; 9: 162-164.
3. Alfonso E, Kenyon KR, Ormerod LD et al. Pseudomonas corneoscleritis. American Journal of Ophthalmology 1987; 103: 90-98.
4. Templeton WC, Eiferman RA, Snyder JW et al. Serratia keratitis transmitted by contaminated eyedroppers. American Journal of Ophthalmology 1982; 93: 723-726.
5. Schein OD, Wasson PJ, Boruchoff SA et al. Microbial keratitis associated with contaminated ocular medications. American Journal of Ophthalmology 1988; 105: 361-365.
6. Clark PJ, Ong B. Contamination of diagnostic ophthalmic solutions in primary eye care settings. Military Medicine 1997; 162: 501-506.
7. Schein OD, Hibberd PL, Starck T et al. Microbial contamination of in-use ocular medications. Archives of Ophthalmology 1992; 110: 82-85.
8. Wessels IF, Bekendam P, Calvin WS et al. Open drops in ophthalmology offices: expiration and contamination. Ophthalmic Surgery and Lasers 1999; 30: 540-546.
9. Palmberg R, Gutierrez YS, Miller D et al. Potential bacterial contamination of eyedrops used for tonometry. American Journal of Ophthalmology 1994; 117: 578-582.
10. Stevens JD, Matheson MM. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing. British Journal of Ophthalmology 1992; 76: 36-38.
11. Hovding G, Sjursen H. Bacterial contamination of drops and dropper tips in in-use multi-dose eye drop bottles. Acta Ophthalmologica 1982;60: 213-222.
12. Ford JL, Brown MW, Hunt PB. A note on the contamination of eye drops following use by hospital outpatients. Journal of Clinical Hospital Pharmacology 1985; 10: 203-209.
13. Storey ES, Gerding PA, Scherba G et al. Survival of equine herpesvirus- 4, feline herpesvirus-1, and feline calicivirus in multidose ophthalmic solutions. Veterinary Ophthalmology 2002; 5: 263-267.
14. Stiles J, Krohne S, Rankin A et al. The efficacy of 0.5% proparacaine stored at room temperature. Veterinary Ophthalmology 2001; 4: 205-207.
15. Geyer O, Bottone EJ, Podos SM et al. Microbial contamination of medications used to treat glaucoma. British Journal of Ophthalmology 1995; 79: 376-379.
16. Coad CT, Osato MS, Wilhelmus KR. Bacterial contamination of eyedrop dispensers. American Journal of Ophthalmology 1984; 98: 548-551.
17. Aslund B, Olson OT. Studies on in-use microbial contamination of irrigation solutions. Acta Pharmaceutica Suecica 1978; 1: 165-171.
18. Oldham GB, Andrews V. Control of microbial contamination in unpreserved eyedrops. British Journal of Ophthalmology 1996; 80: 588-591.
19. Livingstone DJ, Hanlon GW, Dyke S. Evaluation of an extended period of use for preserved eye drops in hospital practice. British Journal of Ophthalmology 1998; 82: 473-475.
20. Romanowski EG, Barnhorst DA, Kowalski RP et al. The survival of herpes simplex virus in multidose office ophthalmic solutions. American Journal of Ophthalmology 1999; 128: 239-240.
21. Dantas PEC, Uesugui E, Nishiwaki-Dantas MC et al. Antibacterial activity of anesthetic solutions and preservatives. Cornea 2000; 19: 353-354.
22. Mullin GS, Rubinfeld RS. The antibacterial activity of topical anesthetics. Cornea 1997; 16: 662-665.
23. Whitley RD, Burgess EC, Moore CP. Microbial isolates of the normal equine eye. Equine Veterinary Journal Supplement 1983; 2: 138-140.
24. Gerding PA, Kakoma I. Microbiology of the canine and feline eye. Veterinary Clinics of North America: Small Animal Practice 1990; 20: 615-625.
25. Urban M, Wyman M, Rheins M et al. Conjunctival flora of clinically normal dogs. Journal of the American Veterinary Medical Association 1972; 161: 201-206.